ArticleThe journal of pain2024

Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy.

George Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.